These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31337801)
41. The relationship between glycemic control and morbidity and mortality for diabetics on dialysis. Tzamaloukas AH; Murata GH; Zager PG; Eisenberg B; Avasthi PS ASAIO J; 1993; 39(4):880-5. PubMed ID: 8123921 [TBL] [Abstract][Full Text] [Related]
42. Predicting mortality of incident dialysis patients in Taiwan--a longitudinal population-based study. Wu PH; Lin YT; Lee TC; Lin MY; Kuo MC; Chiu YW; Hwang SJ; Chen HC PLoS One; 2013; 8(4):e61930. PubMed ID: 23626754 [TBL] [Abstract][Full Text] [Related]
43. [Chronic dialysis in advanced age patients: a reasonable therapeutic alternative?]. Duclos J; Cubillos B; Salgado MC; Olea C; Casanova D Rev Med Chil; 1991 Nov; 119(11):1259-63. PubMed ID: 9723077 [TBL] [Abstract][Full Text] [Related]
44. Diabetes: changing the fate of diabetics in the dialysis unit. Broumand B Blood Purif; 2007; 25(1):39-47. PubMed ID: 17170536 [TBL] [Abstract][Full Text] [Related]
45. Dialytic therapy for diabetic patients with terminal renal failure. Miles AM; Friedman EA Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):868-75. PubMed ID: 7922226 [TBL] [Abstract][Full Text] [Related]
46. Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Matsushima M; Tajima N; LaPorte RE; Orchard TJ; Tull ES; Gower IF; Kitagawa T Diabetologia; 1995 Feb; 38(2):236-43. PubMed ID: 7713320 [TBL] [Abstract][Full Text] [Related]
47. Predialysis management and predictors for early mortality in uremic patients who die within one year after initiation of dialysis therapy. Biesenbach G; Hubmann R; Janko O; Schmekal B; Eichbauer-Sturm G Ren Fail; 2002 Mar; 24(2):197-205. PubMed ID: 12071593 [TBL] [Abstract][Full Text] [Related]
48. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Stack AG; Murthy BV; Molony DA Kidney Int; 2004 Jun; 65(6):2398-408. PubMed ID: 15149353 [TBL] [Abstract][Full Text] [Related]
49. Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre. Abderrahim E; Zouaghi K; Hedri H; Ben Abdallah T; Ben Hamida F; Kaaroud H; Goucha R; Ben Abdallah N; Khiari K; El Younsi F; Ben Moussa F; Kheder A; Ben Maïz H Diabetes Metab; 2001 Nov; 27(5 Pt 1):584-90. PubMed ID: 11694858 [TBL] [Abstract][Full Text] [Related]
50. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis. Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292 [TBL] [Abstract][Full Text] [Related]
51. Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria. Agarwal R; Debella YT; Giduma HD; Light RP Nephrol Dial Transplant; 2012 Jan; 27(1):310-7. PubMed ID: 21669884 [TBL] [Abstract][Full Text] [Related]
52. Dialysis in patients with diabetic nephropathy: CAPD versus hemodialysis. Lee HB; Song KI; Kim JH; Cha MK; Park MS Perit Dial Int; 1996; 16 Suppl 1():S269-74. PubMed ID: 8728205 [TBL] [Abstract][Full Text] [Related]
53. A comparison of medium-term survival between peritoneal dialysis and haemodialysis in accordance with the initial vascular access. García-Cantón C; Rufino-Hernández JM; Vega-Díaz N; Pérez-Borges P; Bosch-Benítez-Parodi E; Saavedra P; García-Gómez C; Marrero-Robayna S; Maceira-Cruz B; Rodríguez-Pérez JC; Checa-Andrés MD Nefrologia; 2013; 33(5):629-39. PubMed ID: 24089154 [TBL] [Abstract][Full Text] [Related]
54. [Which method of dialysis for the type 2 diabetic?]. Vigneau C; Trolliet P; Labeeuw M; Pouteil-Noble C Nephrologie; 2000; 21(4):173-8. PubMed ID: 10976432 [TBL] [Abstract][Full Text] [Related]
55. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease. Drechsler C; Kalim S; Wenger JB; Suntharalingam P; Hod T; Thadhani RI; Karumanchi SA; Wanner C; Berg AH Kidney Int; 2015 Jun; 87(6):1201-8. PubMed ID: 25671766 [TBL] [Abstract][Full Text] [Related]
56. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005). Villar E; Chang SH; McDonald SP Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610 [TBL] [Abstract][Full Text] [Related]
57. Markers for survival in dialysis: a seven-year prospective study. Avram MM; Mittman N; Bonomini L; Chattopadhyay J; Fein P Am J Kidney Dis; 1995 Jul; 26(1):209-19. PubMed ID: 7611254 [TBL] [Abstract][Full Text] [Related]
58. Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Plantinga LC; Fink NE; Levin NW; Jaar BG; Coresh J; Levey AS; Klag MJ; Powe NR Am J Kidney Dis; 2007 Jun; 49(6):831-40. PubMed ID: 17533026 [TBL] [Abstract][Full Text] [Related]
59. Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis. Rhee CM; Kovesdy CP; Ravel VA; Streja E; Sim JJ; You AS; Gatwood J; Amin AN; Molnar MZ; Nguyen DV; Kalantar-Zadeh K J Ren Nutr; 2019 Mar; 29(2):82-90. PubMed ID: 30448393 [TBL] [Abstract][Full Text] [Related]